These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8953566)

  • 1. Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.
    Battino M; Littarru GP; Gorini A; Villa RF
    Neurochem Res; 1996 Dec; 21(12):1505-14. PubMed ID: 8953566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.
    Villa RF; Arnaboldi R; Ghigini B; Gorini A
    Neurochem Res; 1992 Nov; 17(11):1147-54. PubMed ID: 1461362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.
    Villa RF; Arnaboldi R; Ghigini B; Gorini A
    Neurochem Res; 1994 Mar; 19(3):229-36. PubMed ID: 8177363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.
    Marzatico F; Café C; Taborelli M; Benzi G
    Neurochem Res; 1993 Oct; 18(10):1101-6. PubMed ID: 8255359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
    Schwartzman RJ; Alexander GM
    Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
    Degryse AD; Colpaert FC
    Brain Res Bull; 1986 May; 16(5):561-71. PubMed ID: 3488798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex.
    Villa RF; Gorini A; Hoyer S
    Neurochem Res; 2009 Dec; 34(12):2102-16. PubMed ID: 19495970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
    Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
    Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
    Ghilardi MF; Chung E; Bodis-Wollner I; Dvorzniak M; Glover A; Onofrj M
    Life Sci; 1988; 43(3):255-62. PubMed ID: 3260986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical evaluations in skeletal muscles of primates with MPTP Parkinson-like syndrome.
    Pastoris O; Dossena M; Foppa P; Catapano M; Ferrari R; Dagani F
    Pharmacol Res; 1995 Jun; 31(6):361-9. PubMed ID: 8685074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).
    Curti D; Izzo E; Benzi G
    Neurosci Lett; 1994 Feb; 168(1-2):213-6. PubMed ID: 8028778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.
    Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O
    Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.